Clinical trial / 2017
Caffeine failed to improve motor symptoms in individuals with Parkinson disease
A randomized trial assigned 121 individuals with Parkinson disease to 200 mg of caffeine twice daily or placebo for 6 to 18 months. Caffeine did not change motor scores at six months compared to placebo (-0.48 points, 95% CI -3.21 to 2.25 on MDS-UPDRS-III). Participants receiving caffeine experienced a slight increase in dyskinesia and worse cognitive scores (0.66 points worse on Montreal Cognitive Assessment, 95% CI 0.01 to 1.32).
- Study type
- Randomized controlled trial
- Who was studied
- 121 adults with Parkinson disease
- What was measured
- motor symptoms (MDS-UPDRS-III) and secondary disease manifestations
THE PAPER
Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.
Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE. Neurology, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.